Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


23rd Annual International Light Scattering Colloquium

22 Oct 2012 - 23 Oct 2012 - Santa Barbara, CA, USA



Bookmark and Share


Wyatt Technology is pleased to announce that it is hosting its 23rd Annual International Light Scattering Colloquium (ILSC). At this year’s ILSC, Wyatt plans to celebrate its 30th anniversary with a series of presentations from industry leaders across a wide range of application areas.

Featured sessions include:

• Dr. Adrian Apetri, Crucell “Life in a Pharmaceutical Company Before and After Light Scattering"
• Dr. Tapan Das, Pfizer Inc. "Predicting Aggregation Trend in Protein Therapeutics: Role of Biophysical Methods"
• Dr. Stefan Fischer, F. Hoffman-La Roche Ltd. “Challenges in the Development of Protein Formulations”
• Professor Stephen Harding, University of Nottingham "MALS - A Success Story in Glycopolymer Research"
• Professor Axel Mueller, University of Bayreuth “Self-Organized Multicompartment Nanostructures From New Triblock Terpolymers"
• Professor Andre Nel, University of California Los Angeles "Use of Nanomaterial Libraries and Their Characterization to Understand the Potential Environmental Impact of This Technology"
• Professor Christopher Roberts, University of Delaware "Probing Protein Aggregation Mechanisms and Revisiting Protein-Protein Interactions from 'Low' to 'High' Concentrations"
• Dr. Peter Schuck, National Institutes of Health “Protein Refractive Index Increments and the Structure and Function of Gamma Crystallin”
For more information or to register, please contact Lindsey East at marketing@wyatt.com or call +1 805 681 9009 ext 210.

Further information
Scientific News
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!